Recombinant human growth hormone induced hypercalcemia
10.3760/cma.j.issn.1008-5734.2017.01.013
- VernacularTitle:重组人生长激素致高钙血症
- Author:
Huaidong PENG
1
;
Xia FENG
1
;
Ruolun WANG
1
Author Information
1. 510260,广州医科大学附属第二医院药学部
- Publication Type:Journal Article
- Keywords:
Human growth hormone;
Hypercalcemia
- From:
Adverse Drug Reactions Journal
2017;19(1):57-58
- CountryChina
- Language:Chinese
-
Abstract:
A 50-year-old woman received surgical treatment because of severe gastrointestinal perforation and acute diffuse peritonitis. She received subcutaneous injection of recombinant human growth hormone 5 U once daily to promote the surgical wound healing. The patient′s serum calcium was 2. 51 mmol/L before treatment. On day 3 of drug administration, the serum calcium was 2. 62 mmol/L. On day 13, the serum calcium was 3. 17 mmol/L. Recombinant human growth hormone was stopped. One week later, the serum calcium was decreased to 2. 55 mmol/L.
